Home » Topics » Regulatory » Patents

Patents
RSS

Teijin Pharma presents CDK4/cyclin D3 and/or CDK6/cyclin D3 inhibitors

June 21, 2018

Genentech, Roche and Paraza Pharma patent TRPA1 antagonists

June 20, 2018

Boehringer Ingelheim identifies free fatty acid receptor 1 agonists

June 20, 2018

Glycogen synthase kinase 3 inhibitors patented by Bristol-Myers Squibb

June 19, 2018

Shanghai Institute of Materia Medica discovers BTK inhibitors

June 19, 2018

Hedgehog pathway modulators patented by Development Center for Biotechnology, DCB-USA

June 19, 2018

Xavier University of Louisiana divulges androgen receptor signaling inhibitors

June 19, 2018

Teijin Pharma divulges cyclin-dependent kinase CDK4/cyclin D3 and CDK6/cyclin D3 inhibitors

June 18, 2018

CV6 Therapeutics identifies dUTPase inhibitors

June 18, 2018

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent TLR7 agonists

June 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...